Drug induced arousal from the permanent vegetative state

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Zolpidem, an omega-1 selective GABA-A receptor agonist, is primarily used for insomnia.
• Its potential efficacy in treating brain damage, particularly in persistent vegetative states, warrants investigation.

Observation:

• Three patients in a persistent vegetative state for over three years received daily zolpidem.
• Assessments included the Glasgow Coma Scale and Rancho Los Amigos Scale before and after treatment.
• Long-term responses were monitored over 3-6 years.

Findings:

• Zolpidem induced transient morning arousal in all patients.
• Glasgow Coma Scale scores improved from 6-9 to 10-15.
• Rancho Los Amigos Cognitive Scale scores increased from I-II to V-VII.
• Sustained efficacy and no adverse effects were observed after 3-6 years of daily use.

Implications:

• Zolpidem demonstrates potential as an effective treatment for restoring neurological function in select patients with persistent vegetative states.
• This suggests a possible therapeutic role for GABA-A agonists beyond their sedative properties.
• Further research is needed to elucidate the mechanisms and identify patient subgroups who may benefit most.